SGLT2 inhibitors may help reduce the risk of nephrolithiasis in patients with type 2 diabetes, including those with co-existing gout. Recent large-scale studies support that sodium-glucose ...
Consistent adherence to sodium-glucose cotransporter 2 (SGLT2) inhibitors in individuals with type 2 diabetes reduces the risk of hospitalization, supporting targeted interventions to improve ...
Find lists of blood pressure medications commonly used to treat hypertension and the names of medications prescribed less often.
ORLANDO -- Major cardiovascular event risk in patients with inflammatory bowel disease (IBD) was no greater with Janus kinase (JAK) inhibitors than with tumor necrosis factor (TNF) inhibitors, ...
(RTTNews) - Biomea Fusion Inc. (BMEA) announced that it has presented new data from its COVALENT-111 study evaluating Icovamenib for type-2 diabetes at the 23rd World Congress on Insulin Resistance, ...
NEW YORK & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ajax Therapeutics, Inc., a biopharmaceutical company developing next generation JAK inhibitors for patients with myeloproliferative neoplasms (MPNs), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results